Vivus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VIVUS, and what generic alternatives to VIVUS drugs are available?
VIVUS has one approved drug.
There are six US patents protecting VIVUS drugs.
There are thirty-eight patent family members on VIVUS drugs in seventeen countries and three supplementary protection certificates in two countries.
Summary for Vivus
| International Patents: | 38 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Vivus: | See patent lawsuits for Vivus |
Drugs and US Patents for Vivus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-001 | Jul 17, 2012 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-002 | Jul 17, 2012 | AB | RX | Yes | No | 9,011,906 | ⤷ Subscribe | ⤷ Subscribe | |||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-001 | Jul 17, 2012 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-001 | Jul 17, 2012 | AB | RX | Yes | No | 9,011,905 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-002 | Jul 17, 2012 | AB | RX | Yes | No | 8,895,057 | ⤷ Subscribe | ⤷ Subscribe | |||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-001 | Jul 17, 2012 | AB | RX | Yes | No | 8,580,298 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-004 | Jul 17, 2012 | AB | RX | Yes | Yes | 8,580,299 | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vivus
Paragraph IV (Patent) Challenges for VIVUS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 3.75 mg/23 mg, 7.5 mg/46 mg, 11.25 mg/69 mg, 15 mg/92 mg | ➤ Subscribe | 2013-07-18 |
International Patents for Vivus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0914991 | ⤷ Subscribe |
| Canada | 2727313 | ⤷ Subscribe |
| Brazil | PI0914985 | ⤷ Subscribe |
| South Korea | 20110044847 | ⤷ Subscribe |
| Israel | 209875 | ⤷ Subscribe |
| Japan | 2017078083 | ⤷ Subscribe |
| Japan | 5752595 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vivus Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2317997 | CR 2021 00049 | Denmark | ⤷ Subscribe | PRODUCT NAME: PHENTERMIN OG TOPIRAMAT; NAT. REG. NO/DATE: 63166, 63167, 63168, 63169 20210705; FIRST REG. NO/DATE: IS IS/1/21/018/01-04 20210212 |
| 2317997 | 2190050-1 | Sweden | ⤷ Subscribe | PRODUCT NAME: PHENTERMINE AND TOPIRAMATE; NAT. REG. NO/DATE: 59574-59577 20210617; FIRST REG.: IS IS/1/21/018/01-04 20210212 |
| 2317997 | CA 2021 00049 | Denmark | ⤷ Subscribe | PRODUCT NAME: PHENTERMIN OG TOPIRAMAT; NAT. REG. NO/DATE: 63166, 63167, 63168, 63169 20210705; FIRST REG. NO/DATE: IS IS/1/21/018/01-04 20210212 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
